Form 8-K - Current report:
SEC Accession No. 0001437749-25-009484
Filing Date
2025-03-27
Accepted
2025-03-27 08:32:34
Documents
16
Period of Report
2025-03-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20250319_8k.htm   iXBRL 8-K 29549
2 EXHIBIT 5.1 ex_795011.htm EX-5.1 14769
7 hklogo35px.jpg GRAPHIC 8086
  Complete submission text file 0001437749-25-009484.txt   218267

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250326.xsd EX-101.SCH 4114
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250326_def.xml EX-101.DEF 13905
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250326_lab.xml EX-101.LAB 18375
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250326_pre.xml EX-101.PRE 13937
18 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250319_8k_htm.xml XML 5061
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 25775458
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)